Nadja van 't Hoff (@nadjavanthoff) 's Twitter Profile
Nadja van 't Hoff

@nadjavanthoff

ID: 1613916711564058625

calendar_today13-01-2023 15:11:54

5 Tweet

35 Followers

52 Following

Nadja van 't Hoff (@nadjavanthoff) 's Twitter Profile Photo

🎉 New on arXiv: My paper on identifying causal effects for nonbinary treatments with multiple instruments! Check it out here: arxiv.org/abs/2311.17575

Giovanni Mellace (@giomellace) 's Twitter Profile Photo

Very excited to attend and present a poster on my project with Nadja van 't Hoff and Arthur Lewbel "Limited Monotonicity and the CC-LATE" at the (EC)^2 conference in Manchester. Also pretty happy about my hotel room view ☺️ sites.google.com/view/2023ec2/p…

Very excited to attend and present a poster on my project with <a href="/nadjavanthoff/">Nadja van 't Hoff</a> and <a href="/lewbel/">Arthur Lewbel</a>   "Limited Monotonicity and the CC-LATE" at the (EC)^2 conference in Manchester. 
Also pretty happy about my hotel room view ☺️ 
sites.google.com/view/2023ec2/p…
Giovanni Mellace (@giomellace) 's Twitter Profile Photo

Check out our new working paper on the causal effect of the Danish "fat tax" on consumption of several products. Joint project with Nadja van 't Hoff, Christian M. Dahl, and Sinne Smed. #Econtwitter arxiv.org/abs/2312.11481

Giovanni Mellace (@giomellace) 's Twitter Profile Photo

Looking to hire a talented and dedicated econometrician? I highly recommend Nadja van 't Hoff. We collaborated with Arthur Lewbel on "LiM and the CC-LATE", now R&R at The Review of Economics and Statistics (REStat). In her JMP, Nadja develops novel identification results for settings with non-binary, ordered treatments.

Looking to hire a talented and dedicated econometrician? I highly recommend <a href="/nadjavanthoff/">Nadja van 't Hoff</a>. We collaborated with <a href="/lewbel/">Arthur Lewbel</a> on "LiM and the CC-LATE", now R&amp;R at <a href="/restatjournal/">The Review of Economics and Statistics (REStat)</a>. In her JMP, Nadja develops novel identification results for settings with non-binary, ordered treatments.